Who is the typical psychedelics user? Methodological challenges for research in psychedelics use and its consequences
Nordic Studies on Alcohol and Drugs February 1, 2021 DOI: 10.1177/1455072520963787 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Methodological review Peer reviewed |
|---|---|
| Citations | 44 |
| Key findings | Divergent findings on the consequences of psychedelics use may be explained by different research strategies exploring different segments of the user population. |
Abstract
Aims: This article argues that despite a resurgence in research on psychedelics over the last two decades, we still have little insight into the psychedelics user population. Furthermore, there is currently little agreement between researchers as to the long-term mental health consequences of psychedelics use.
Design: In a methodological review of a range of studies in psychedelics use, it is demonstrated that these studies tend to focus on specific segments of the user population while excluding others. These population segments are probably connected to different patterns of use, which in turn are likely to result in different long-term consequences.
Results: The divergent findings on the consequences of psychedelics use may be explained, at least in part, by the fact that different research strategies explore different segments of the user population. Studies focusing on user segments with problematic usage patterns tend to find that psychedelics use is negative for mental health, while studies on infrequent users tend to find that psychedelics use is positive for mental health.
Conclusion: Because the field of psychedelics studies lacks a reliable model of the user population, it is difficult for researchers to contextualise and assess the broader validity of their findings. To remedy this situation, the article presents three theoretical models of the user population that afford us with tentative means of contextualising findings and thereby may clarify present disagreements.
Citations in the library
Cited by 33
- Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience. Scientific Reports May 24, 2022
- Pattern breaking: a complex systems approach to psychedelic medicine Neuroscience of Consciousness 2023
- On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review ACS Pharmacology & Translational Science March 11, 2021
- Day trip to hell: A mixed methods study of challenging psychedelic experiences Journal of Psychedelic Studies May 27, 2021
- Minorities' Diminished Psychedelic Returns: Income and Educations Impact on Whites, Blacks, Hispanics, and Asians. Journal of Racial and Ethnic Health Disparities June 1, 2025
and 28 more in the library
Cites 26
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
and 21 more in the library